Regeneron Pharmaceuticals (REGN)
$504.27
0.00 (0.00%)
REGN Stock Quote Delayed 20 Minutes
Previous Close
$504.27
Market Cap
53.43B
PE Ratio
40.86
EPS
12.34
Volume (Avg. Vol.)
246
Day's Range
504.27 - 504.27
52-Week Range
271.37 - 518.00
Dividend & Yield
N/A (N/A)
REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News
Stock Market Today: Huge Jobs Miss; Amazon Prime Day Delay
Stocks slipped, but didn't plummet in the stock market today despite a horrendous jobs report that highlight the impact of Covid-19.
3 Big Stock Charts for Thursday: Kellogg, Regeneron Pharmaceuticals, Newmont
April Fool's Day took many long-side traders by surprise. Thursday's big stock charts feature ones that showed resilience while the markets sank.
A Market Roadmap Shows the Stimulus Will Save the Economy
Matt McCall is confident that, at least in the long term, the stimulus package will inject cash into the economy and help bring new highs.
3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals
Tuesday's big stock charts feature three companies that are contributing, in their own ways, to the fight against the coronavirus.
Regeneron Stock May Need More Than the Coronavirus
The coronavirus is an immediate catalyst for Regeneron stock but it's also too unreliable to provide buyers with lasting confidence.
Buy Regeneron Stock for Coronavirus 2.0 and Beyond
Regeneron stock is one of the top names in the markets this year “thanks” to the coronavirus. But microbial threats down the line ensure that REGN is no flash in the pan.
Stock Market Today: Coronavirus Sparks 1,000-Point Dow Fall
At one point, the Dow Jones slid 1,000 and the Nasdaq was down more than 4% thanks to the coronavirus. Here's the stock market today.
4 Top Stock Trades for Tuesday: SPY, QQQ, MSFT, REGN
The SPY and QQQ were our focus, while Microsoft and Regeneron were our other top stock trades for Tuesday.
3 Big Stock Charts for Thursday: Kraft Heinz, Wabtec, and Regeneron Pharmaceuticals
Thursday's big stock charts detail the hopes for 3 stocks trying to recover from multi-year lows.
Regeneron Pharmaceuticals Earnings: REGN Stock Rockets 7% on Q3 Beat
Regeneron Pharmaceuticals (REGN) earnings for the biotechnology company's third quarter of 2019 have REGN stock soaring on Tuesday.
Why This Just Might Be the Biggest Week for CARA Stock
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
